Suchergebnisse - "Dattola, Annunziata"

PubPharm (91)

1

The new Italian SIDAPA Baseline Series for patch testing (2023) : an update according to the new regulatory pathway for contact allergens

enthalten in: Italian journal of dermatology and venereology | 2024

von Stingeni, L. | Bianchi, L. | Caroppo, E. | +105

2

Awareness of obesity among patients with psoriasis

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2024

von Bellinato, F. | Gisondi, P. | Balato, A. | +15

3

Efficacy and safety of tildrakizumab in elderly patients : real-world multicenter study (ESTER - study)

enthalten in: The Journal of dermatological treatment | 2024

von Orsini, D. | Caldarola, G. | Dattola, A. | +19

4

Spesolimab for the treatment of generalized pustular psoriasis : real life experience

enthalten in: Italian journal of dermatology and venereology | 2024

von Dattola, A. | Taliano, A. | Rallo, A. | +2

5

Bimekizumab for the Treatment of Plaque Psoriasis With Involvement of Genitalia : A 16-Week Multicenter Real-World Experience - IL PSO (Italian Landscape Psoriasis)

enthalten in: Dermatology practical & conceptual | 2024

von Orsini, D. | Malagoli, P. | Balato, A. | +42

6

Therapeutic Potential of Spesolimab-Sbzo in the Management of Generalized Pustular Psoriasis Flares in Adults : Evidence to Date

enthalten in: Psoriasis (Auckland, N.Z.) | 2024

von Rega, F. | Trovato, F. | Bortone, G. | +3

7

Gender perspective in psoriasis : a scoping review and proposal of strategies for improved clinical practice by European dermatologists

enthalten in: International journal of women's dermatology | 2023

von Gonzalez-Cantero, A. | Constantin, M. | Dattola, A. | +3

8

A multidisciplinary approach for patients with moderate-to-severe psoriasis : an advisable network of management

enthalten in: Italian journal of dermatology and venereology | 2023

von Bianchi, L. | Caldarola, G. | Campione, E. | +5

9

A Real-Life Study on the Use of Tildrakizumab in Psoriatic Patients

enthalten in: Pharmaceuticals (Basel, Switzerland) | 2023

von Campione, E. | Lambiase, S. | Gaeta Shumak, R. | +10

10

Efficacy and Microbiota Modulation Induced by LimpiAL 2.5%, a New Medical Device for the Inverse Psoriasis Treatment

enthalten in: International journal of molecular sciences | 2023

von Pietrangelo, L. | Dattola, A. | Magnifico, I. | +7

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]